213 related articles for article (PubMed ID: 30185079)
21. Chaperone-mediated autophagy: roles in neuroprotection.
Cai Z; Zeng W; Tao K; E Z; Wang B; Yang Q
Neurosci Bull; 2015 Aug; 31(4):452-8. PubMed ID: 26206599
[TBL] [Abstract][Full Text] [Related]
22. alpha-synuclein degradation by autophagic pathways: a potential key to Parkinson's disease pathogenesis.
Xilouri M; Vogiatzi T; Vekrellis K; Stefanis L
Autophagy; 2008 Oct; 4(7):917-9. PubMed ID: 18708765
[TBL] [Abstract][Full Text] [Related]
23. LAMP2A as a therapeutic target in Parkinson disease.
Xilouri M; Brekk OR; Kirik D; Stefanis L
Autophagy; 2013 Dec; 9(12):2166-8. PubMed ID: 24145820
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic potential of autophagy-enhancing agents in Parkinson's disease.
Moors TE; Hoozemans JJ; Ingrassia A; Beccari T; Parnetti L; Chartier-Harlin MC; van de Berg WD
Mol Neurodegener; 2017 Jan; 12(1):11. PubMed ID: 28122627
[TBL] [Abstract][Full Text] [Related]
25. Chaperone-Mediated Autophagy.
Yang Q; Wang R; Zhu L
Adv Exp Med Biol; 2019; 1206():435-452. PubMed ID: 31776997
[TBL] [Abstract][Full Text] [Related]
26. Malfunctioning of Chaperone-Mediated Autophagy in Parkinson's Disease: Feats, Constraints, and Flaws of Modulators.
Tripathi MK; Rajput C; Mishra S; Rasheed MSU; Singh MP
Neurotox Res; 2019 Jan; 35(1):260-270. PubMed ID: 29949106
[TBL] [Abstract][Full Text] [Related]
27. Aberrant interaction between Parkinson disease-associated mutant UCH-L1 and the lysosomal receptor for chaperone-mediated autophagy.
Kabuta T; Furuta A; Aoki S; Furuta K; Wada K
J Biol Chem; 2008 Aug; 283(35):23731-8. PubMed ID: 18550537
[TBL] [Abstract][Full Text] [Related]
28. Heat Shock Protein 90 in Parkinson's Disease: Profile of a Serial Killer.
Mansour HM; Mohamed AF; Khattab MM; El-Khatib AS
Neuroscience; 2024 Jan; 537():32-46. PubMed ID: 38040085
[TBL] [Abstract][Full Text] [Related]
29. The Antioxidative Role of Chaperone-Mediated Autophagy as a Downstream Regulator of Oxidative Stress in Human Diseases.
Le S; Fu X; Pang M; Zhou Y; Yin G; Zhang J; Fan D
Technol Cancer Res Treat; 2022; 21():15330338221114178. PubMed ID: 36131551
[TBL] [Abstract][Full Text] [Related]
30. The coming of age of chaperone-mediated autophagy.
Kaushik S; Cuervo AM
Nat Rev Mol Cell Biol; 2018 Jun; 19(6):365-381. PubMed ID: 29626215
[TBL] [Abstract][Full Text] [Related]
31. Molecular chaperones as rational drug targets for Parkinson's disease therapeutics.
Kalia SK; Kalia LV; McLean PJ
CNS Neurol Disord Drug Targets; 2010 Dec; 9(6):741-53. PubMed ID: 20942788
[TBL] [Abstract][Full Text] [Related]
32. Renin-angiotensin system as a potential target for new therapeutic approaches in Parkinson's disease.
Perez-Lloret S; Otero-Losada M; Toblli JE; Capani F
Expert Opin Investig Drugs; 2017 Oct; 26(10):1163-1173. PubMed ID: 28836869
[TBL] [Abstract][Full Text] [Related]
33. Chaperone-mediated autophagy components are upregulated in sporadic inclusion-body myositis muscle fibres.
Cacciottolo M; Nogalska A; D'Agostino C; Engel WK; Askanas V
Neuropathol Appl Neurobiol; 2013 Dec; 39(7):750-61. PubMed ID: 23452232
[TBL] [Abstract][Full Text] [Related]
34. Rational drug discovery design approaches for treating Parkinson's disease.
Van der Schyf CJ
Expert Opin Drug Discov; 2015 Jul; 10(7):713-41. PubMed ID: 26054694
[TBL] [Abstract][Full Text] [Related]
35. Altered expression of autophagic genes in the peripheral leukocytes of patients with sporadic Parkinson's disease.
Wu G; Wang X; Feng X; Zhang A; Li J; Gu K; Huang J; Pang S; Dong H; Gao H; Yan B
Brain Res; 2011 Jun; 1394():105-11. PubMed ID: 21514572
[TBL] [Abstract][Full Text] [Related]
36. Activating Autophagy as a Therapeutic Strategy for Parkinson's Disease.
Fowler AJ; Moussa CE
CNS Drugs; 2018 Jan; 32(1):1-11. PubMed ID: 29492779
[TBL] [Abstract][Full Text] [Related]
37. Investigational α-synuclein aggregation inhibitors: hope for Parkinson's disease.
Török N; Majláth Z; Szalárdy L; Vécsei L
Expert Opin Investig Drugs; 2016 Nov; 25(11):1281-1294. PubMed ID: 27677932
[TBL] [Abstract][Full Text] [Related]
38. Targeting the Autophagy/Lysosomal Degradation Pathway in Parkinson's Disease.
Rivero-Ríos P; Madero-Pérez J; Fernández B; Hilfiker S
Curr Neuropharmacol; 2016; 14(3):238-49. PubMed ID: 26517050
[TBL] [Abstract][Full Text] [Related]
39. Chaperone-Mediated Autophagy in Neurodegenerative Diseases and Acute Neurological Insults in the Central Nervous System.
Kanno H; Handa K; Murakami T; Aizawa T; Ozawa H
Cells; 2022 Apr; 11(7):. PubMed ID: 35406769
[TBL] [Abstract][Full Text] [Related]
40. The complexity in regulation of MEF2D by chaperone-mediated autophagy.
Yang Q; Mao Z
Autophagy; 2009 Oct; 5(7):1073-4. PubMed ID: 19738442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
